Evaluation of Pulpotomy Using Two Different Agents in Mature Anterior Teeth With Pulpitis

NCT06468085 — Not applicable, Unknown, 48 participants, Ain Shams University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Clinical and Radiographic Evaluation of Premixed Bioceramic Putty and Biodentine™ Pulpotomy in Mature Permanent Anterior Teeth With Signs of Pulpitis: A Randomized Controlled Trial

RegistryNCT06468085
StatusUnknown
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment48 (Estimated)
SponsorAin Shams University (Other)
ConditionsPulpitis
Interventionspremixed Bioceramic NeoPUTTY®, Biodentine™, Root canal treatment (Procedure)
Datesstart 2024-07-01 (estimated), primary completion 2026-01-01 (estimated), completion 2026-07-01 (estimated), first posted 2024-06-21, last updated 2024-06-21

Related Papers Related Patents Related Grants Related Experts
All trials for Pulpitis All trials of premixed Bioceramic NeoPUTTY® All trials of Biodentine™

-Summary

the study will evaluate the clinical and radiological success of mature permanent anterior teeth pulpotomy in children and adolescents with signs of pulpitis using two different Biomimetic materials (NeoPutty® and Biodentine™) as a pulp dressing material in comparison to root canal treatment at 3, 6, 9 and 12 months follow up.

Expand all sections  ·  Collapse all

+Detailed description

In this randomized controlled trial, A total number of 75 mature vital permanent anterior teeth with recent trauma or deep caries in children aged between 9 and 14 years will be included. Patients will be randomly allocated into three study groups: group A (premixed bioceramic NeoPutty®) test group, group B (Biodentine™) test group and group C (root canal treatment) control group. Cases will be evaluated clinically and radiographically to obtain baseline data. Local anesthesia will be administered and then rubber dam isolation will be performed. Pulpotomy procedure will be performed after hemostasis followed by covering pulp stump with Premixed Bioceramic or Biodentine™ according to the corresponding group then final composite restoration will be applied. Root canal treatment will be performed to the control group followed by composite restoration. Blinded clinical evaluation will be done at baseline, 3, 6, 9 and 12 months.

+Arms and interventions

ArmTypeInterventionsDescription
Group A: The premixed Bioceramic NeoPUTTY® groupExperimentalProcedure: premixed Bioceramic NeoPUTTY®Cases will be evaluated clinically and radiographically to obtain baseline data. Local anesthesia will be administered and then rubber dam isolation will be performed. Pulpotomy procedure will be performed after hemostasis followed by covering pulp stump with Premixed Bioceramic NeoPUTTY® then final composite restoration will be applied.
Group B: The Biodentine™ groupExperimentalProcedure: Biodentine™Cases will be evaluated clinically and radiographically to obtain baseline data. Local anesthesia will be administered and then rubber dam isolation will be performed. Pulpotomy procedure will be performed after hemostasis followed by covering pulp stump with Biodentine™ then final composite restoration will be applied.
Group C: the root canal treatment groupActive comparatorProcedure: Root canal treatmentRoot canal treatment will be performed to the control group followed by composite restoration.
  • premixed Bioceramic NeoPUTTY® (Procedure): Pulpotomy procedure will be performed after hemostasis followed by covering pulp stump with Premixed Bioceramic then final composite restoration will be applied. clinical evaluation will be done at baseline, 3, 6, 9 and 12 months.
  • Biodentine™ (Procedure): Pulpotomy procedure will be performed after hemostasis followed by covering pulp stump with Premixed Bioceramic or Biodentine™ according to the corresponding group then final composite restoration will be applied. clinical evaluation will be done at baseline, 3, 6, 9 and 12 months.
  • Root canal treatment (Procedure): Root canal treatment will be performed to the control group followed by composite restoration. clinical evaluation will be done at baseline, 3, 6, 9 and 12 months.

+Outcome measures

Primary outcomes

  • Clinical success [3, 6, 9 and 12 months follow up]: Absence of pain related to the treated teeth, including patient reported pain or sensitivity to percussion/palpation. No evidence of swelling of supporting soft tissue or presence of sinus tract. Absence of excessive mobility affecting treated teeth.
  • Radiographic success [3, 6, 9 and 12 months follow up]: No Internal or external root resorption. No Periapical radiolucency.

Secondary outcomes

  • Evaluation of tooth discoloration. [3, 6, 9 and 12 months follow up]: Evaluation of tooth discoloration using the VITA Easyshade V digital spectrophotometer.

+Eligibility

Sex: All, ages: 9 Years to 14 Years, accepts healthy volunteers

Inclusion Criteria:

* Children and adolescents of both sexes aged between 9 and 14 years old.
* Vital mature permanent anterior teeth with deep caries lesions that approach the pulp with signs of pulpitis and respond positive to cold pulp testing.
* Vital mature permanent anterior teeth with pulpal exposure that occurred during caries excavation.
* Patients presented immediately after suffering recent trauma (at the same day) to mature anterior teeth that had resulted in a crown fracture with pulp exposure.

Exclusion Criteria:

* Teeth with signs of infection such as swelling, sinus tract or pathological mobility or excessive mobility.
* Teeth with excessive bleeding from amputated radicular stumps
* Teeth showing radiographic evidence of pathologic root resorption, periapical pathology and calcifications in the canals.
* Lack of patient/parent compliance and cooperation.
* Children who are physically or mentally disabled or having any medical condition that will complicate the treatment.
* Patients allergic to any medicaments used.

+Investigators